Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate versus heparin anticoagulation for pediatric continuous renal replacement therapy
TCTR20230421001Phase 3Recruiting
- Sponsor
- Suvikrom Law
- Start
- Jun 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of trisodium citrate, heparin in acute kidney failure (AKF), kidney failure, sponsored by Suvikrom Law. Started Jun 2023; status: recruiting.
02
Drugs
trisodium citrateheparin
03
Conditions
acute kidney failure (AKF)kidney failure
Beyond the preview
Go deeper on TCTR20230421001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230421001.